Latest News

Focusing on cutting-edge technologies and research advancements,
sharing Aniphe BioLab’s achievements in scientific innovation, Professional insights
and practical experience in the fields of laboratory animals and preclinical research.

Publish an article

2026-10-29

Naming Genetically Engineered Mice (Part II): From Being Understandable to Being Written Correctly

2026-10-29

How should a multi-disease composite mouse model be constructed? Let’s take a look at the CKM approach.

2026-08-12

2026 CKM Guidelines Released: Chronic Diseases Enter the Era of Integrated Cardiorenal-Metabolic Management—It’s Time to Rethink Animal Models

2026-08-12

A Guide to Safe Mouse Handling | Manual on Mouse Transport Protocols and Troubleshooting

[Good News] Aniphe BioLab has won the provincial first prize in the “Right Here in Jiangsu” Youth Entrepreneurship Competition!

On December 16, the provincial finals of the “Right Here in Jiangsu” Youth Entrepreneurship Competition, hosted by the Jiangsu Provincial Department of Human Resources and Social Security, concluded successfully in Changzhou.

This competition has attracted a stellar lineup of experts, with entries spanning multiple cutting-edge fields, making the rivalry exceptionally fierce. Among the participants are university research teams that address pressing public‑health challenges and specialize in medical devices, as well as established companies that have secured hundreds of millions in funding and demonstrate robust capabilities in R&D translation. Amid this intense contest among formidable contenders, Jiangsu Aniphe BioLab Co., Ltd. submitted… Preclinical Drug Efficacy Testing Service Project ,凭借创新的服务模式与突出的社会效益，脱颖而出、大放异彩，最终成功斩获大赛一等奖！

As a benchmark competition in the province’s youth entrepreneurship landscape, this event focuses on three core tracks—“Livelihood Needs + Entrepreneurial Projects,” “Technical Skills + Entrepreneurial Projects,” and “Labor‑Brand Development + Entrepreneurial Projects”—precisely aligning market demand with entrepreneurial potential. It has drawn high‑quality startup initiatives and talented young entrepreneurs from across the province to participate enthusiastically. After rigorous rounds of selection, only 125 outstanding projects advanced to the finals, with 51 competing in the Livelihood Needs track, where competition was particularly fierce.

Achieving outstanding results in such a high‑profile, highly competitive event not only underscores the exceptional value of the project but also serves as a resounding affirmation of the Aniphe BioLab founding team’s formidable capabilities.

The preclinical drug efficacy testing service project that has just received this award precisely addresses the core R&D needs of the biopharmaceutical sector. Backed by cutting-edge, innovative technologies, it has established a highly efficient and precise specialized testing service platform, with distinctive competitive advantages particularly in the area of aging‑related research and assessment using aged mouse models.

At the roadshow, the company’s CEO, Yu Xin, shared: “We have deeply invested in this field—not as a mere trend‑following move, but because we truly understand the industry’s pain points. Our customers don’t just want standard laboratory animals; they need research ‘tools’ that can seamlessly align with their R&D needs and deliver stable, reliable results. For instance, in the arena of aging‑related drug development, we have specifically established standardized aged‑mouse models to provide critical support for evaluating the efficacy of relevant therapeutics. Over the past five years, we have consistently positioned ourselves as ‘friends of time,’ leveraging sustained expertise to ensure that our offerings outperform others, while staying true to our original mission: using scientific research to improve people’s lives.” He then went on to systematically outline the platform’s operating mechanisms and its broader social value.

Since its inception, Aniphe BioLab has consistently adhered to an innovation-driven development philosophy. Backed by a clear growth strategy, robust technological expertise, and tangible achievements, the company has steadily advanced in the biopharmaceutical startup sector.

Winning the provincial first prize this time is both the fruit of the team’s relentless efforts and a significant milestone in the company’s development. Moving forward, Aniphe BioLab will seize this opportunity to deepen its commitment to the biopharmaceutical sector, continuously refine its service model, and strengthen its technological capabilities, thereby contributing even more to advancing the industry and supporting youth entrepreneurship and innovation.

Follow us to witness the growth and breakthroughs of Aniphe BioLab, and together explore the boundless possibilities of the biopharmaceutical field!

J. Med. Chem.| A comprehensive, innovative strategy for anti‑gastric cancer based on dual targeting and immune activation, employing iridium(III) complexes

Jointly Building Standards, Advancing with Precision | Aniphe BioLab, in collaboration with multiple institutions, has released a group standard for human prostate organoids.